- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Ipilimumab plus nivolumab
Total 6702 results
-
The Netherlands Cancer InstituteRecruitingCutaneous Squamous Cell CarcinomaNetherlands
-
Bradley A. McGregor, MDBristol-Myers Squibb; ExelixisRecruitingRenal Cell Carcinoma | Chromophobe Renal Cell Carcinoma | Papillary Renal Cell Carcinoma | Unclassified Renal Cell Carcinoma | Collecting Duct Renal Cell Carcinoma | Translocation Renal Cell Carcinoma | Unresectable Advanced Renal Cell Carcinoma | Metastatic Ncc Renal Cell CarcinomaUnited States
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdCompletedBroad Solid TumorUnited States, Argentina, Australia, Canada, Chile, Japan, Romania, Singapore
-
Vastra Gotaland RegionBristol-Myers SquibbActive, not recruitingLiver Metastases | Uveal MelanomaSweden
-
TriSalus Life Sciences, Inc.Active, not recruitingHepatocellular Carcinoma | Intrahepatic CholangiocarcinomaUnited States
-
BioNTech US Inc.Apexigen, Inc.TerminatedMetastatic MelanomaUnited States
-
Sarcoma Oncology Research Center, LLCBristol-Myers SquibbRecruitingSAINT:Trabectedin, Ipilimumab and Nivolumab as First Line Treatment for Advanced Soft Tissue SarcomaAdvanced Soft Tissue Sarcoma | Metastatic Soft Tissue SarcomaUnited States
-
Bristol-Myers SquibbActive, not recruitingHepatocellular CarcinomaGermany, Romania, United States, Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Czechia, France, Hong Kong, Italy, Japan, Korea, Republic of, Poland, Puerto Rico, Russian Federation, Singapore, Spain, Switzerland and more
-
ArdigenNational Center for Research and Development, Poland; The Institute of Bioorganic...UnknownMelanoma | Healthy Volunteers | Metagenome | Immunotherapy | MicrobiomePoland
-
Providence Health & ServicesBristol-Myers Squibb; ExelixisActive, not recruitingRefractory Cutaneous MelanomaUnited States
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdCompleted
-
Bristol-Myers SquibbMedarex; Ono Pharma USA IncCompleted
-
University of Texas Southwestern Medical CenterTerminated
-
H. Lee Moffitt Cancer Center and Research InstituteBristol-Myers Squibb; MultiVir, Inc.TerminatedSmall Cell Lung Cancer | Lung Cancer | Relapsed Small Cell Lung CancerUnited States
-
Bristol-Myers SquibbActive, not recruitingA Study of BMS-986253 in Combination With Nivolumab or Nivolumab Plus Ipilimumab in Advanced CancersMelanoma | CancerUnited States, Poland, Italy, Belgium, France, Australia, Canada, Germany, Spain, Sweden, Switzerland, United Kingdom
-
Shanghai Henlius BiotechRecruitingHealthy Male VolunteersChina
-
Sumitomo Pharma America, Inc.Completed
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdCompletedVarious Advanced CancerUnited States, Belgium, France, Germany, Japan, Korea, Republic of, Mexico, Netherlands, Spain, Taiwan, United Kingdom
-
Robert R. McWilliams, MDBristol-Myers Squibb; Hoosier Cancer Research NetworkActive, not recruiting
-
National Cancer Institute (NCI)SuspendedDiffuse Glioma | Secondary Glioblastoma | Glioblastoma, IDH-Wildtype | Astrocytoma, IDH-Mutant, Grade 4United States, Puerto Rico
-
Ultimovacs ASACompletedMalignant MelanomaUnited States, Belgium, United Kingdom, Norway
-
Radboud University Medical CenterBristol-Myers SquibbActive, not recruitingProstatic Neoplasms, Castration-ResistantNetherlands
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Bristol-Myers SquibbTerminatedNeuroendocrine Tumors | Carcinoid TumorUnited States
-
Kristen GanjooBristol-Myers SquibbCompletedSoft Tissue SarcomaUnited States
-
ExelixisActive, not recruitingRenal Cell CarcinomaUnited States, Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, Czechia, Finland, France, Germany, Hong Kong, Hungary, Israel, Italy, Korea, Republic of, Mexico, Netherlands, New Zealand, Poland, Singapore, Spain, Taiwan, United...
-
University of California, IrvineExelixisRecruitingHCC | Hepatocellular CarcinomaUnited States
-
Dana-Farber Cancer InstituteBiohaven Pharmaceuticals, Inc.TerminatedMelanoma | Metastatic MelanomaUnited States
-
Jounce Therapeutics, Inc.Completed
-
H. Lee Moffitt Cancer Center and Research InstituteRecruitingMerkel Cell Carcinoma | Cutaneous Melanoma | Cutaneous Squamous Cell CarcinomaUnited States
-
The Netherlands Cancer InstituteBristol-Myers SquibbRecruitingColon CarcinomaNetherlands
-
University of Wisconsin, MadisonBristol-Myers Squibb; National Cancer Institute (NCI); AnYxis Immuno-Oncology... and other collaboratorsSuspended
-
H. Lee Moffitt Cancer Center and Research InstituteBristol-Myers Squibb; Gilead SciencesActive, not recruitingMetastatic Urothelial CarcinomaUnited States
-
Roberto PiliBristol-Myers Squibb; Syndax Pharmaceuticals; Indiana University School of MedicineActive, not recruitingRenal Cell CarcinomaUnited States
-
Takayuki YoshinoOno Pharmaceutical Co. LtdRecruiting
-
Fondazione Melanoma OnlusClinical Research Technology S.r.l.Active, not recruitingMetastatic MelanomaItaly, Germany, Spain, Greece, Austria, France, Poland, Sweden, Switzerland, United Kingdom
-
Hoffmann-La RocheCompletedMelanomaUnited States, Italy, Australia, France, Spain, Netherlands
-
National Cancer Institute (NCI)TerminatedMetastatic Melanoma | Stage III Cutaneous Melanoma AJCC v7 | Stage IV Cutaneous Melanoma AJCC v6 and v7 | Stage IIIC Cutaneous Melanoma AJCC v7 | BRAF V600E Mutation Present | BRAF V600K Mutation Present | Stage IIIA Cutaneous Melanoma AJCC v7 | Stage IIIB Cutaneous Melanoma AJCC v7United States
-
Abramson Cancer Center at Penn MedicineTerminatedRenal Cell Carcinoma | Renal Cell Carcinoma Stage IVUnited States
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdActive, not recruitingUrothelial CancerRussian Federation, United States, Brazil, Spain, Chile, Korea, Republic of, Argentina, Australia, Canada, China, Czechia, Denmark, Finland, France, Germany, Greece, Israel, Italy, Japan, Mexico, Netherlands, Norway, Peru, Poland, Romania, Swed... and more
-
Jeffrey ClarkeCompletedNon-small Cell Lung CancerUnited States
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdActive, not recruitingHepatocellular CarcinomaUnited States, Singapore, Spain, United Kingdom, Germany, Italy, Canada, France, Hong Kong, Japan, Korea, Republic of, Puerto Rico, Taiwan
-
University of Alabama at BirminghamWithdrawnCarcinosarcoma of Ovary | Carcinosarcoma of Uterus | Carcinosarcoma of VaginaUnited States
-
ArdigenMałopolskie Centre of EntrepreneurshipUnknownNon Small Cell Lung Cancer | Immunotherapy | Neoantigens | Neoepitopes | Next Generation Sequencing (NGS) | Personalized Neoantigen Cancer VaccinePoland
-
Bristol-Myers SquibbCompleted
-
Italian Network for Tumor BiotherapyBristol-Myers SquibbCompletedMetastatic Malignant MelanomaItaly
-
Scott AntoniaRecruitingLung Cancer MetastaticUnited States
-
ArdigenNational Center for Research and Development, PolandUnknownMelanoma | Non Small Cell Lung Cancer | Metagenome | Immunotherapy | MicrobiomePoland
-
Lahey ClinicCompletedDry Eye SyndromeUnited States
-
Bristol-Myers SquibbActive, not recruitingAdvanced or Metastatic Solid TumorsUnited States, Spain, Italy, Canada, Germany, United Kingdom, Denmark, Finland
-
M.D. Anderson Cancer CenterRecruitingRenal Cell CarcinomaUnited States